Bradmer Pharmaceuticals Inc.
|
|||
| Mailing Address: | c/o Wildeboer Dellelce LLP 1 First Canadian Place, Suite 810 Toronto, Ontario M5X 1A9 |
Head Office Address: | c/o Wildeboer Dellelce LLP 1 First Canadian Place, Suite 810 Toronto, Ontario M5X 1A9 |
| Contact Name: | Dr. Mark C. Rogers | Principal Regulator: | Ontario |
| Business e-mail address: | Short Form Prospectus Issuer: | No | |
| Telephone Number: | 416 361-3121 | Reporting Jurisdictions: | Ceased Reporting |
| Fax Number: | 416 361-1790 | Stock Exchange: | N/A |
| Date of Formation: | Jun 16 2005 | Stock Symbol: | |
| Jurisdiction Where Formed: | Ontario | Auditor: | DMCT, LLP |
| Industry Classification: | other | General Partner: | |
| CUSIP Number: | 10463R | Transfer Agent: | Equity Transfer Services Inc. |
| Financial Year-End: | Dec 31 | Size of Issuer (Assets): | Under $5,000,000 |
|
This company is a previous issuer to Galaxy Digital Holdings Ltd. 
|
